A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

Clinical trial NCT01186588 · COMPLETED

Trial details

NCT number: NCT01186588
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatic Insufficiency

Start date: 2010-08-01
Primary completion: 2011-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.